Inflammatory Pseudotumor After Total Hip Arthroplasty-An Increasingly Recognized Complication

Steve T. L. Pambayi , Zhi Zhao , Hongjun Peng , Ruihao Xia , Xishan Zhu , Wangdui Suolang , Gang Wang , Xiaoou Li , Yi Zeng

Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (7) : 1311 -1327.

PDF (3454KB)
Orthopaedic Surgery ›› 2026, Vol. 18 ›› Issue (7) :1311 -1327. DOI: 10.1111/os.70334
REVIEW ARTICLE
Inflammatory Pseudotumor After Total Hip Arthroplasty-An Increasingly Recognized Complication
Author information +
History +
PDF (3454KB)

Abstract

Inflammatory pseudotumor (IP) is an increasingly recognized etiological factor in the failure of total hip arthroplasty (THA). It is a non-neoplastic, non-infectious mass encircling a hip prosthesis following arthroplasty and may appear as cystic, solid, or mixed tissue. Although initially associated with metal-on-metal (MoM) bearing surfaces, IP formation can also occur with other bearing types. Recognized risk factors include female sex, specific genetic predispositions, MoM bearings, large femoral head size, modular femoral stem designs, elevated metal ion levels, and wear debris from polyethylene components. IP contributes to THA failure through both mechanical and inflammatory mechanisms, often leading to pain, instability, or implant loosening. Diagnosis relies heavily on imaging modalities, including plain radiographs, ultrasound, CT, and MRI with metal artifact reduction sequences (MARS-MRI), which help delineate the extent and characteristics of IP lesions. A multimodal imaging approach is essential for accurate assessment and surgical planning. Management strategies are guided by clinical presentation and radiographic findings, such as IP size and anatomical location, ranging from close observation in asymptomatic cases to revision surgery in symptomatic or progressive disease. IP is therefore an important, imaging-detectable cause of THA failure, and awareness of its presentation and diagnostic features is critical for timely intervention and improved patient outcomes.

Keywords

arthroplasty / magnetic resonance imaging / pseudotumor / ultrasonography

Cite this article

Download citation ▾
Steve T. L. Pambayi, Zhi Zhao, Hongjun Peng, Ruihao Xia, Xishan Zhu, Wangdui Suolang, Gang Wang, Xiaoou Li, Yi Zeng. Inflammatory Pseudotumor After Total Hip Arthroplasty-An Increasingly Recognized Complication. Orthopaedic Surgery, 2026, 18 (7) : 1311-1327 DOI:10.1111/os.70334

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

M. Mastel, A. Boisvert, R. Moore, F. Sutherland, and J. Powell, “Metallosis Following Hip Arthroplasty: Two Case Reports,” Journal of Medical Case Reports 16, no. 1 (2022): 115.

[2]

G. Perino, I. De Martino, L. Zhang, et al., “The Contribution of the Histopathological Examination to the Diagnosis of Adverse Local Tissue Reactions in Arthroplasty,” EFORT Open Reviews 6, no. 6 (2021): 399–419.

[3]

A. Cannella, T. Greco, C. Polichetti, et al., “A Rare Case of Adverse Reaction to Metal Debris in a Ceramic-On-Ceramic Total Hip Replacement,” Journal of Functional Biomaterials 13, no. 3 (2022): 145.

[4]

M. Kimura, N. Kaku, Y. Kubota, H. Tagomori, and H. Tsumura, “Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Adverse Local Tissue Reactions Near Metal Implants After Total Hip Arthroplasty: A Preliminary Report,” Clinics in Orthopedic Surgery 13, no. 3 (2021): 320–328.

[5]

M. F. Koff, M. A. Gao, J. P. Neri, et al., “Adverse Local Tissue Reactions Are Common in Asymptomatic Individuals After Hip Resurfacing Arthroplasty: Interim Report From a Prospective Longitudinal Study,” Clinical Orthopaedics and Related Research 479, no. 12 (2021): 2633–2650.

[6]

A. Chen and A. P. Kurmis, “Understanding Immune-Mediated Cobalt/Chromium Allergy to Orthopaedic Implants: A Meta-Synthetic Review,” Art 6, no. 1 (2024): 1.

[7]

F. Eltit, Q. Wang, and R. Wang, “Mechanisms of Adverse Local Tissue Reactions to Hip Implants,” Frontiers in Bioengineering and Biotechnology 7 (2019): 176.

[8]

H. Wakabayashi, M. Hasegawa, Y. Naito, S. Tone, and A. Sudo, “Long-Term Outcome of Metal-On-Metal Total Hip Arthroplasty With Modular Neck Stem,” Journal of Clinical Medicine 13, no. 6 (2024): 1525.

[9]

D. Stimolo, F. Muratori, L. Cucurullo, G. Scoccianti, M. Innocenti, and D. A. Campanacci, “Pseudotumor Following Total Hip Arthroplasty: Experience of a Tertiary Referral Center and Proposal of the New “PCS” Classification System,” Archives of Orthopaedic and Trauma Surgery 145, no. 1 (2025): 168.

[10]

M. Cerchiaro, G. Trovarelli, A. Angelini, et al., “When Is a Two-Stage Surgical Procedure Indicated in the Treatment of Pseudotumors of the Hip? A Retrospective Study of 21 Cases and a Review of the Literature,” Journal of Clinical Medicine 13, no. 3 (2024): 815.

[11]

B. J. McGrory, J. J. Jacobs, Y.-M. Kwon, and Y. Fillingham, “Standardizing Terms for Tribocorrosion-Associated Adverse Local Tissue Reaction in Total Hip Arthroplasty,” Arthroplasty Today 6, no. 2 (2020): 196–200.

[12]

Z.-Y. Huang, S.-C. Wang, H.-J. Zhang, L. Shao, Z.-L. Di, and K. Tao, “Pseudotumor and Delayed Recurrent Dislocation After Total Hip Arthroplasty With a Modular Femoral Neck: A Case Report,” Medicine 101, no. 11 (2022): e29056.

[13]

A. Davies, H. Willert, P. Campbell, I. Learmonth, and C. Case, “An Unusual Lymphocytic Perivascular Infiltration in Tissues Around Contemporary Metal-On-Metal Joint Replacements,” JBJS 87, no. 1 (2005): 18–27.

[14]

H. C. van der Veen, I. H. Reininga, W. P. Zijlstra, M. F. Boomsma, S. K. Bulstra, and J. J. van Raay, “Pseudotumour Incidence, Cobalt Levels and Clinical Outcome After Large Head Metal-On-Metal and Conventional Metal-On-Polyethylene Total Hip Arthroplasty: Mid-Term Results of a Randomised Controlled Trial,” Bone & Joint Journal 97, no. 11 (2015): 1481–1487.

[15]

M. Min, C. Xing, P. Xu, X. Wei, and L. Fan, “Case Report: Formation and Recurrence of Inflammatory Pseudotumor After Metal-On-Metal Hip Arthroplasty,” Frontiers in Medicine 11 (2024): 1422230.

[16]

N. S. Sagoo, R. Sharma, C. S. Johnson, K. Stephenson, and K. L. Aya, “Pseudotumor in the Setting of Metal-On-Metal Total Hip Arthroplasty,” Cureus 12, no. 5 (2020): e8255, https://10.7759/cureus.8255.

[17]

H.-P. Wang, M.-Y. Wang, Y.-P. Lan, Z.-D. Tang, Q.-F. Tao, and C.-Y. Chen, “Application of 3D-Printed Prosthesis in Revision Surgery With Large Inflammatory Pseudotumour and Extensive Bone Defect: A Case Report,” World Journal of Clinical Cases 10, no. 36 (2022): 13388–13395.

[18]

L. T. Kleeman, D. Goltz, T. M. Seyler, et al., “Association Between Pseudotumor Formation and Patient Factors in Metal-On-Metal Total Hip Arthroplasty Population,” Journal of Arthroplasty 33, no. 7 (2018): S259–S264.

[19]

M. H. Hjorth, I. Mechlenburg, K. Soballe, L. Roemer, S. S. Jakobsen, and M. Stilling, “Higher Prevalence of Mixed or Solid Pseudotumors in Metal-On-Polyethylene Total Hip Arthroplasty Compared With Metal-On-Metal Total Hip Arthroplasty and Resurfacing Hip Arthroplasty,” Journal of Arthroplasty 33, no. 7 (2018): 2279–2286.

[20]

T. Ishida, T. Tateiwa, Y. Takahashi, T. Masaoka, T. Shishido, and K. Yamamoto, “Do Polyethylene Wear Particles Affect the Development of Pseudotumor in Total Hip Arthroplasty? A Minimum 15-Year Follow-Up,” Journal of Orthopaedic Surgery and Research 18, no. 1 (2023): 147.

[21]

Y.-M. Kwon, T.-Y. Tsai, W. A. Leone, and M. H. L. Liow, “Sensitivity and Specificity of Metal Ion Levels in Predicting “Pseudotumors” due to Taper Corrosion in Patients With Dual Taper Modular Total Hip Arthroplasty,” Journal of Arthroplasty 32, no. 3 (2017): 996–1000.

[22]

S. J. Incavo, “Goals and Challenges of Identifying Asymptomatic Pseudotumors in Patients Treated With Total Hip Arthroplasty: Commentary on an Article by Young-Min Kwon, MD, PhD, Et al.:“Asymptomatic Pseudotumors in Patients With Taper Corrosion of a Dual-Taper Modular Femoral Stem: MARS-MRI and Metal Ion Study”,” JBJS 98, no. 20 (2016): e93.

[23]

T. P. Davis and T. Davis, “Metal-On-Metal Hip Arthroplasty: A Comprehensive Review of the Current Literature,” Cureus 15, no. 11 (2023): e48238, https://10.7759/cureus.48238.

[24]

C. P. van Lingen, H. B. Ettema, B. H. Bosker, and C. C. Verheyen, “Ten-Year Results of a Prospective Cohort of Large-Head Metal-On-Metal Total Hip Arthroplasty: A Concise Follow-Up of a Previous Report,” Bone & Joint Open 3, no. 1 (2022): 61–67.

[25]

Y.-M. Kwon, S. Khormaee, M. H. L. Liow, T.-Y. Tsai, A. A. Freiberg, and H. E. Rubash, “Asymptomatic Pseudotumors in Patients With Taper Corrosion of a Dual-Taper Modular Femoral Stem: MARS-MRI and Metal Ion Study,” JBJS 98, no. 20 (2016): 1735–1740.

[26]

F. Mariotti, F. Castagnini, M. De Paolis, et al., “One-Stage Complete Eradication and Revision Hip due to Pseudotumor in Metal-On-Metal Hip Arthroplasty,” Annals of Joint 8 (2023): 14.

[27]

D. Xing, C. Yang, R. Li, et al., “Severe Wear and Multiple Pseudotumor Formation due to Revision for Ceramic Head Breakage After Ceramic-On-Ceramic Total Hip Arthroplasty: A Case Report,” BMC Musculoskeletal Disorders 20 (2019): 1–8.

[28]

C. Ciatti, P. Maniscalco, S. Bosio, C. P. Pagliarello, G. Bianchi, and F. Quattrini, “Pseudotumor From Ceramic-On-Ceramic Total Hip Arthroplasty,” International Journal of Surgery Case Reports 116 (2024): 109374.

[29]

T. Ishida, T. Tateiwa, Y. Takahashi, et al., “Do Polyethylene Supra-Macroparticles Lead to Pseudotumor Formation in Metal-On-Polyethylene Total Hip Arthroplasty?,” Arthroplasty Today 6, no. 3 (2020): 526–531.

[30]

S. M. Kurtz, H. A. Gawel, and J. D. Patel, “History and Systematic Review of Wear and Osteolysis Outcomes for First-Generation Highly Crosslinked Polyethylene,” Clinical Orthopaedics and Related Research 469, no. 8 (2011): 2262–2277.

[31]

D. J. Hall, R. Pourzal, and J. J. Jacobs, “What Surgeons Need to Know About Adverse Local Tissue Reaction in Total Hip Arthroplasty,” Journal of Arthroplasty 35, no. 6 (2020): S55–S59.

[32]

B. K. Kilb, A. P. Kurmis, M. Parry, et al., “Frank Stinchfield Award: Identification of the At-Risk Genotype for Development of Pseudotumors Around Metal-On-Metal THAs,” Clinical Orthopaedics and Related Research 476, no. 2 (2018): 230–241.

[33]

G. A. Sheridan, M. Hanlon, A. Welch-Phillips, et al., “Identification of Protective and ‘at RISK'HLA Genotypes for the Development of Pseudotumours Around Metal-On-Metal Hip Resurfacings: A Case-Control Study,” Bone & Joint Open 4, no. 3 (2023): 182–187.

[34]

J. R. Berstock, R. P. Baker, G. C. Bannister, and C. P. Case, “Histology of Failed Metal-On-Metal Hip Arthroplasty; Three Distinct Sub-Types,” Hip International 24, no. 3 (2014): 243–248.

[35]

P. Campbell, E. Ebramzadeh, S. Nelson, K. Takamura, K. De Smet, and H. C. Amstutz, “Histological Features of Pseudotumor-Like Tissues From Metal-On-Metal Hips,” Clinical Orthopaedics and Related Research 468, no. 9 (2010): 2321–2327.

[36]

E. A. Phillips, G. R. Klein, H. E. Cates, S. M. Kurtz, and M. Steinbeck, “Histological Characterization of Periprosthetic Tissue Responses for Metal-On-Metal Hip Replacement,” Journal of Long-Term Effects of Medical Implants 24, no. 1 (2014): 13–23.

[37]

C. Smeekes, B. Schouten, M. Nix, et al., “Pseudotumor in Metal-On-Metal Hip Arthroplasty: A Comparison Study of Three Grading Systems With MRI,” Skeletal Radiology 47 (2018): 1099–1109.

[38]

H. C. van der Veen, I. H. Reininga, W. P. Zijlstra, M. F. Boomsma, S. K. Bulstra, and J. J. van Raay, “Pseudotumours, Cobalt and Clinical Outcome in Small Head Metal-On-Metal Versus Conventional Metal-On-Polyethylene Total Hip Arthroplasty,” Hip International 30, no. 1 (2020): 56–63.

[39]

A. Pozzuoli, A. Berizzi, A. Crimì, et al., “Metal Ion Release, Clinical and Radiological Outcomes in Large Diameter Metal-On-Metal Total Hip Arthroplasty at Long-Term Follow-Up,” Diagnostics 10, no. 11 (2020): 941.

[40]

A. Persson, T. Eisler, H. Bodén, F. Krupic, O. Sköldenberg, and O. Muren, “Revision for Symptomatic Pseudotumor After Primary Metal-On-Polyethylene Total Hip Arthroplasty With a Standard Femoral Stem,” JBJS 100, no. 11 (2018): 942–949.

[41]

H. Wakabayashi, M. Hasegawa, Y. Naito, S. Tone, and A. Sudo, “Minimum 10-Year Results of Modular Metal-On-Metal Total Hip Arthroplasty,” Journal of Clinical Medicine 11, no. 21 (2022): 6505.

[42]

C. W. Grote, P. C. Cowan, D. W. Anderson, and K. J. Templeton, “Pseudotumor From Metal-On-Metal Total Hip Arthroplasty Causing Unilateral Leg Edema: Case Presentation and Literature Review,” Bioresearch Open Access 7, no. 1 (2018): 33–38.

[43]

K. C. Ilo, H. S. Hothi, J. A. Skinner, and A. J. Hart, “Metal-On-Metal Total Hip Arthroplasty: Does Increasing Modularity Affect Clinical Outcome?,” Hip International 32, no. 5 (2022): 677–684.

[44]

A. K. Matthies, J. A. Skinner, H. Osmani, J. Henckel, and A. J. Hart, “Pseudotumors Are Common in Well-Positioned Low-Wearing Metal-On-Metal Hips,” Clinical Orthopaedics and Related Research 470, no. 7 (2012): 1895–1906.

[45]

M. H. Hjorth, I. Mechlenburg, K. Soballe, L. Roemer, and M. Stilling, “The Correlation Between Activity Level, Serum-Ion Concentrations and Pseudotumours in Patients With Metal-On-Metal Hip Articulations and Metal-On-Polyethylene Total Hip Articulations,” Journal of Orthopaedic Translation 18 (2019): 74–83.

[46]

M. Palazzuolo, A. Antoniadis, L. Delaune, I. Tornare, and J. Wegrzyn, “Comparison of the Long-Term Cause of Failure and Survivorship of Four Hundred and Twenty Seven Metal-On-Metal Hip Arthroplasties: Resurfacing Versus Large Head Total Hip Arthroplasty,” International Orthopaedics 45, no. 12 (2021): 3075–3081.

[47]

E. Holappa, J. Kettunen, H. Miettinen, H. Kröger, and S. Miettinen, “Long-Term Survival Analysis of Cementless Large-Diameter Head Metal-On-Metal Total Hip Arthroplasty,” Archives of Orthopaedic and Trauma Surgery 143, no. 7 (2023): 4437–4446.

[48]

A. V. Lombardi, Jr., K. R. Berend, M. J. Morris, J. B. Adams, and M. A. Sneller, “Large-Diameter Metal-On-Metal Total Hip Arthroplasty: Dislocation Infrequent but Survivorship Poor,” Clinical Orthopaedics and Related Research 473, no. 2 (2015): 509–520.

[49]

R. N. de Steiger, A. Hatton, Y. Peng, and S. Graves, “What Is the Risk of THA Revision for ARMD in Patients With Non-Metal-On-Metal Bearings? A Study From the Australian National Joint Replacement Registry,” Clinical Orthopaedics and Related Research 478, no. 6 (2020): 1244–1253.

[50]

S. Meriem, A. Antoniadis, M. Palazzuolo, and J. Wegrzyn, “The Use of Dual Mobility Cups in Revision Total Hip Arthroplasty for Failed Large Head Metal-On-Metal Bearings,” International Orthopaedics 48, no. 3 (2024): 719–727.

[51]

J. D. Lizcano, S. Marei, P. F. Sharkey, et al., “Does the Type of Femoral Stem and/or Femoral Head Influence the Rate of Adverse Local Tissue Reactions After Primary Total Hip Arthroplasty?,” Journal of Arthroplasty 40, no. 2 (2025): S121–S124.

[52]

C. Ciatti, L. Andriollo, C. Asti, et al., “The Role of Femoral Head Size in Metal-On-Metal Hip Arthroplasty: Analysis of a Cohort of 3813 Patients With Long Term Follow-Up,” Archives of Orthopaedic and Trauma Surgery 1–10 (2024): 4809–4818.

[53]

P. Mertl and M. Dehl, “Femoral Stem Modularity,” Orthopaedics & Traumatology, Surgery & Research 106, no. 1S (2020): S35–S42.

[54]

M. S. Abdelaal, E. Zachwieja, and P. F. Sharkey, “Severe Corrosion of Modular Dual Mobility Acetabular Components Identified During Revision Total Hip Arthroplasty,” Arthroplasty Today 8 (2021): 78–83.

[55]

D. A. Porter, R. M. Urban, J. J. Jacobs, J. L. Gilbert, J. A. Rodriguez, and H. J. Cooper, “Modern Trunnions Are More Flexible: A Mechanical Analysis of THA Taper Designs,” Clinical Orthopaedics and Related Research 472, no. 12 (2014): 3963–3970.

[56]

S. K. Fokter, N. Noč, V. Levašič, M. Hanc, and J. Zajc, “Dual-Modular Versus Single-Modular Stems for Primary Total Hip Arthroplasty: A Long-Term Survival Analysis,” Medicina 59, no. 2 (2023): 290.

[57]

M. Hasegawa, Y. Naito, T. Yamaguchi, S. Miyazaki, H. Wakabayashi, and A. Sudo, “Factors Associated With Symptomatic Pseudotumors Following Metal-On-Metal Total Hip Arthroplasty,” BMC Musculoskeletal Disorders 17 (2016): 1–5.

[58]

S. Jabbouri, G. Lee, T. Stonecipher, and M. Nawalany, “Intrapelvic Pseudotumor Presenting With Deep Vein Thrombosis After Hip Replacement With Metal-On-Metal Bearing Surface Implant: A Case Report,” JBJS Case Connector 11, no. 2 (2021): e20.

[59]

C. Fary, G. E. Thomas, A. Taylor, D. Beard, A. Carr, and S. Glyn-Jones, “Diagnosing and Investigating Adverse Reactions in Metal on Metal Hip Implants,” BMJ 343 (2011): d7441.

[60]

F. Pogliacomi, P. Schiavi, F. Calderazzi, et al., “Is There a Relation Between Clinical Scores and Serum Ion Levels After MoM-THA? One Year Results in 383 Implants,” Acta Bio Medica: Atenei Parmensis 91, no. Suppl 14 (2020): e2020014.

[61]

M. T. Houdek, M. J. Taunton, C. C. Wyles, P. J. Jannetto, D. G. Lewallen, and D. J. Berry, “Synovial Fluid Metal Ion Levels Are Superior to Blood Metal Ion Levels in Predicting an Adverse Local Tissue Reaction in Failed Total Hip Arthroplasty,” Journal of Arthroplasty 36, no. 9 (2021): 3312–3317.e1.

[62]

R. T. Mikkelsen, M. Schou, T. Torfing, O. Graumann, S. Overgaard, and C. Varnum, “Sensitivity and Specificity for Detecting Pseudotumors in Patients With Hip Resurfacing Arthroplasty, Metal-On-Metal or Metal-On-Polyethylene Total Hip Arthroplasty—MRI Versus Ultrasonography Performed by an Orthopedic Surgery Resident,” Acta Radiologica Open 12, no. 2 (2023): 20584601231152396.

[63]

M. F. Koff, A. J. Burge, and H. G. Potter, “Clinical Magnetic Resonance Imaging of Arthroplasty at 1.5 T,” Journal of Orthopaedic Research 38, no. 7 (2020): 1455–1464.

[64]

A. K. Low, G. S. Matharu, S. J. Ostlere, D. W. Murray, and H. G. Pandit, “How Should We Follow-Up Asymptomatic Metal-On-Metal Hip Resurfacing Patients? A Prospective Longitudinal Cohort Study,” Journal of Arthroplasty 31, no. 1 (2016): 146–151.

[65]

H. Choe, N. Kobayashi, K. Abe, et al., “Targeting of Periprosthetic Muscles for the Ultrasonographic Screening of Hip Abnormalities in Hip Resurfacing Arthroplasty Patients,” Journal of Clinical Medicine 12, no. 8 (2023): 2871.

[66]

R. Wellenberg, H. Ettema, C. Verheyen, M. Maas, and M. Boomsma, “Cross Sectional Imaging of Metal-On-Metal Hip Arthroplasties,” Acta Orthopaedica 86, no. 2 (2015): 272–273.

[67]

J. I. Law, D. A. Crawford, J. B. Adams, and A. V. Lombardi, Jr., “Metal-On-Metal Total Hip Revisions: Pearls and Pitfalls,” Journal of Arthroplasty 35, no. 6 (2020): S68–S72.

[68]

R. D'Ambrosi and N. Ursino, “N-Acetyl-Cysteine Reduces Blood Chromium and Cobalt Levels in Metal-On-Metal Hip Arthroplasty,” Arthroplasty Today 6, no. 2 (2020): 149–152.

[69]

U. Cottino, F. Dettoni, S. Risitano, A. Marmotti, and R. Rossi, “Two-Stage Treatment of a Large Pelvic Cystic Pseudotumor in a Metal-On-Metal Total Hip Arthroplasty,” Joints 5, no. 2 (2017): 121–124.

[70]

L. D. Winter, K. C. Helmig, P. J. Goodwyn, and R. J. Gehlert, “Compression of the Rectum, Bladder, and External Iliac Vein Due to Hip Arthroplasty-Related Pseudotumor,” Cureus 13, no. 12 (2021): e20671, https://10.7759/cureus.20671.

[71]

G. S. Matharu, A. Eskelinen, A. Judge, H. G. Pandit, and D. W. Murray, “Revision Surgery of Metal-On-Metal Hip Arthroplasties for Adverse Reactions to Metal Debris,” Acta Orthopaedica 89, no. 3 (2018): 278–288.

[72]

L. G. Naik, W. Y. Shon, I. C. Clarke, J. G. Moon, P. Mukund, and S. M. Kim, “Pseudotumor and Subsequent Implant Loosening as a Complication of Revision Total Hip Arthroplasty With Ceramic-On-Metal Bearing: A Case Report,” Hip Pelvis 30, no. 4 (2018): 276–281.

Rights & permissions

2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.

PDF (3454KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉